论文部分内容阅读
目的二甲双胍是一种历史悠久的降糖药物,随着降糖药不断推陈出新,二甲双胍在降糖药中仍然举足轻重,本文探讨其优势及前瞻性。讨论二甲双胍降糖药并非刺激胰岛β细胞分泌胰岛素,不导致胰岛素功能衰竭,可降低糖化血红蛋白,降低血脂,减少诱发心肌梗塞的风险,副作用少,安全性好而广泛用于临床。
Aim Metformin is a long history of hypoglycemic drugs, with the constant introduction of new antidiabetic drugs, metformin still plays a decisive role in hypoglycemic agents, this article discusses its advantages and prospective. Discussion Metformin hypoglycemic agents are not stimulated islet β-cell insulin secretion, does not lead to insulin failure, can reduce glycated hemoglobin, lower blood lipids, reduce the risk of myocardial infarction induced, less side effects, safety and widely used in clinical.